RSA and Swissbit Announce New Phishing-Resistant Authentication Solution for Security-First Industries

 BURLINGTON, Mass. - 

(BUSINESS WIRE)--RSA, the security-first identity leader and Swissbit, a long-standing leading expert and manufacturer of storage, security, and embedded IoT solutions, announced a new, next-generation hardware authenticator series today designed to protect highly regulated industries.

The RSA iShield Key 2 series, powered by Swissbit, will provide financial services, energy, healthcare, and other highly regulated organizations with the highest-level of phishing-resistant, passwordless authentication needed to simplify credential management and drive toward Zero Architecture (ZTA). Optimized for the RSA cloud identity and access management (IAM) platform, RSA® ID Plus, the RSA iShield Key 2 series offers premiere security and unparalleled flexibility. The RSA iShield Key 2 series is available for order now and will ship Q4 2024.

“The worst attacks demand the best defenses. That’s why security-first leaders have trusted RSA for decades to defend them from the most damaging cyberattacks. By working with a leader like Swissbit, we can expand our unified identity platform and deliver innovations like the RSA iShield Key 2 that provide a broader range of capabilities, all fortified by the security depth unique to RSA,” said Rohit Ghai, CEO, RSA.

“To secure their operations and stay operational, leaders in finance, healthcare, energy, and manufacturing need strong, phishing-resistant capabilities built to enable users and resist modern attacks. Together, Swissbit and RSA are bringing those innovations to the private sector organizations that need them most,” said Silvio Muschter, CEO of Swissbit AG.

By offering the RSA iShield Key 2 series through ID Plus, RSA and Swissbit can bring organizations key benefits, including:

Secure, phishing-resistant authentication: the RSA DS100, RSA Authenticator App, and the RSA iShield Key 2 series supports FIDO2, smart card, and OTP for legacy applications, providing multi-protocol multi-factor authentication (MFA) for a variety of users and use cases.

FIPS 140-3 validated security: the RSA iShield Key 2 series provides the highest level of cryptographic protection and ensures that every organization’s infrastructure meets the most stringent cybersecurity requirements.

Accelerating Zero Trust maturity: RSA ID Plus allows organizations to meet key ZTA requirements, including implementing centralized credential management and visibility over all access points.

Single sign-on (SSO) and self-service capabilities: users can easily register, update, and manage their credentials with RSA ID Plus, minimizing costs on IT teams and accelerating productivity.

Availability and support

The RSA iShield Key 2 series, powered by Swissbit, is available for order now and will ship at the end of 2024. Both companies will support their customers with comprehensive training and support services to ensure smooth integration and implementation.

Resources:

Download the RSA iShield Key 2 series data sheet

Being your RSA iShield Key 2 series order now

About RSA

The AI-powered RSA Unified Identity Platform protects the world’s most secure organizations from today’s and tomorrow’s highest-risk cyberattacks. RSA provides the identity intelligence, authentication, access, governance, and lifecycle capabilities needed to prevent threats, secure access, and enable compliance. More than 9,000 security-first organizations trust RSA to manage more than 60 million identities across on-premises, hybrid, and multi-cloud environments. For additional information, visit our website to contact sales, find a partner, or learn more about RSA.

About Swissbit

Swissbit AG is the leading European provider of storage, security and embedded IoT solutions for demanding applications. Swissbit combines its unique competencies in storage and embedded IoT technology with its advanced packaging know-how. This expertise allows our customers to reliably store and protect data in industrial, NetCom, automotive, medical and fiscal applications as well as across the Internet of Things (IoT). Swissbit develops and manufactures industrial-grade storage and security products “Made in Germany” with high reliability, long-term availability, and custom optimization. Swissbit was founded in 2001 and has offices in Switzerland, Germany, USA, Japan and Taiwan. For further information, please visit www.swissbit.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20241001333919/en/

Permalink

https://www.aetoswire.com/en/news/1102024418499

Contacts

Media contact:

teamrsa@axicom.com

Five Key Transformative Video Technology Trends by 2035 Revealed at Milestone XPerience Days

6G, surveillance systems with autonomous operation and decision-making, AI-driven ethics and privacy guardians, next-level cybersecurity, and responsible technology are five trends poised to shape the Video Technology sector in the next decade. These insights were presented at the Milestone XPerience Days event, held at Madinat Jumeirah and attended by over 350 attendees across the technology industry.

According to industry experts, these key trends are expected to significantly impact and outline the industry's future. 6G’s ultra-fast speeds and low latency will revolutionise video technology, enabling real-time, high-definition video analytics and global connectivity. Future video technology systems will increasingly operate autonomously while keeping humans in the loop for qualified decision-making. AI-driven ethics and privacy guardians will introduce automated systems that ensure ethical guidelines and privacy protections are enforced by design, ensuring compliance in an increasingly connected world.

Next-level cybersecurity will play a crucial role as video technology integrates with IoT, AI, and quantum computing, countering new vulnerabilities such as deep fakes and encryption threats through advanced detection technologies. Finally, the focus on responsible technology will ensure that emerging systems are used ethically, safeguarding human rights while delivering on the promise of enhanced security and operational efficiency.

Jos Beernink, Vice President, EMEA, at Milestone Systems, emphasised the profound impact these innovations will have: “Video technology is evolving from passive observation to proactive event prediction and influence.” He highlighted that these advancements, driven by AI, IoT, and computer vision, are set to revolutionise how intelligent cities operate, enhancing security measures and operational efficiencies.

The event also highlighted Milestone Systems’ continued growth and innovation in the global video management software and Video Surveillance as a Service (VSaaS) market, projected to reach USD 4.5 billion by 2028, according to market research company Omdia. Advancements in AI, VSaaS, video analytics, and data-driven video technologies fuel this growth.

Beernink concluded, “We’re at the dawn of a new era where video technology will monitor, predict, and influence outcomes.” The Milestone XPerience Days 2024 provided a glimpse into this industry’s future: AI-driven ethics and integrated technologies will enable superior customer experiences in security and across smart cities, healthcare, and more.

Permalink
https://aetoswire.com/en/news/ms0302092024

Contacts

Melwyn Abraham - melwyn@matrixdubai.com

Copeland Unveils Unified Brand Identity Across Product Portfolio

 Copeland Unveils Unified Brand Identity Across Product Portfolio

Industry leader focused on delivering seamless customer experiences while providing next-gen climate solutions

(BUSINESS WIRE)--Copeland, a global leader in sustainable climate solutions, announced today that it has transitioned its extensive product portfolio to align with the Copeland brand. This rebranding initiative represents a significant milestone in Copeland’s journey as a stand-alone company, further solidifying its commitment to delivering innovative climate solutions across global commercial, industrial, refrigeration and residential market sectors. Backed by more than 100 years of innovation, Copeland’s vision is to create sustainable solutions that improve lives and protect the planet today and for future generations.

“Our brand transition is a natural step forward in Copeland’s transformation. With a more consolidated and connected portfolio of brands, we will make it easier for our customers and end-users to navigate our extensive product range,” said Paul Mottershead, vice president of global marketing and communications at Copeland. “This strategic move allows us to meet the evolving needs of our customers, while unifying the next-generation climate solutions that address the HVACR industry’s most pressing challenges.”

Copeland’s product portfolio was previously offered under various brand names. This strategic rebranding aims to provide customers with a more consistent and recognizable brand experience while reinforcing Copeland’s core values of sustainability, reliability and innovation.

In addition to Copeland’s line of compressors, variable speed drives, and refrigeration condensing units, the company is migrating its controls portfolio (i.e., rack, system, facility, environmental and flow controls), enterprise management software and services, leak detection, cargo monitoring, transport solutions and other system components to the Copeland brand. The brands transitioning to the Copeland name include:

Dixell electronics.

Emerson and Alco flow controls, valves and system components.

Emerson rack system facility controls and case controllers.

Emerson leak detection.

Emerson cargo monitoring solutions.

ProAct services and software.

ProAct Transport.

Additionally, the following brands, which are now part of the Copeland brand suite, will remain and play pivotal roles in Copeland’s portfolio:

Sensi – Smart thermostats that enable demand-response capabilities and energy savings in residential and light commercial buildings.

Verdant – Energy management solutions designed to reduce energy consumption in the hospitality and multi-dwelling unit markets.

Vilter – Industrial and commercial compression and controls, specialized for refrigeration, cold storage, heat pump and renewable natural gas (RNG) applications.

White-Rodgers – Traditional thermostats, universal heating controls and gas valves for enhanced comfort and efficiency in residential and commercial spaces.

Cooper-Atkins – Temperature and environmental measurement devices, compliance solutions and wireless monitoring systems for food service and industrial markets.

Under the Copeland umbrella, the product brands above will retain their existing names with an updated look and feel. This approach retains the highly recognized brand names that customers and end-users know and value.

Product packaging and labeling updates to reflect the brand changes are being implemented over the next 6-12 months, ensuring a seamless and recognizable experience across all touchpoints by mid-2025.

Learn more about Copeland’s brands and rebranding efforts at Copeland Brands | Copeland US.

About Copeland

Copeland is a global leader in sustainable heating, cooling, refrigeration and industrial solutions. We help commercial, industrial, refrigeration and residential customers reduce their carbon emissions and improve energy efficiency. We address issues like climate change, growing populations, electricity demands and complex global supply chains with innovations that advance the energy transition, accelerate the adoption of climate-friendly low GWP (Global Warming Potential) and natural refrigerants, and safeguard the world's most critical goods through an efficient and sustainable cold chain. We have over 18,000 employees, with feet on the ground in more than 40 countries - a global presence that makes it possible to serve customers wherever they are in the world and meet challenges with scale and speed. Our industry-leading brands and diversified portfolio deliver innovation and technology proven in over 200 million installations worldwide. Together, we create sustainable solutions that improve lives and protect the planet today and for future generations. For more information, visit copeland.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240930282531/en/

Permalink

https://www.aetoswire.com/en/news/20240930282531r1

Contacts

 

Michelle Crawley

TriComB2B

Michelle.Crawley@TriComB2B.com

937-890-5311

Jenna Petroff

Copeland

Jenna.Petroff@Copeland.com

314-928-9517

 

Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11

 SHANGHAI, China & JERSEY CITY, N.J. 

(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) announced that the phase 3 comparative clinical trial for the investigational Perjeta® (pertuzumab) biosimilar HLX11 met the primary endpoint. In 2022, Henlius entered into a license and supply agreement with Organon for the exclusive commercialization rights to two biosimilar candidates, including HLX11. The agreement licenses the global commercialization rights for the product, except for China, to Organon.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240930000839/en/

The multicenter, randomized, double-blind, parallel-controlled phase 3 clinical study (NCT05346224) aimed to compare the efficacy and safety of HLX11 with reference Perjeta® (pertuzumab) as a neoadjuvant therapy in patients with HER2-positive, HR-negative early, or locally advanced breast cancer as part of a complete treatment regimen. Eligible patients were randomized 1:1 to receive either HLX11 or reference Perjeta® (pertuzumab) in combination with trastuzumab and docetaxel every three weeks for four cycles. The primary endpoint of this study was the total pathological complete response (tpCR) rate assessed by Independent Review Committee (IRC). The secondary endpoints currently being analyzed included tpCR rate assessed by investigators, breast pathologic complete response (bpCR) rate, objective response rate (ORR), event-free survival (EFS), disease-free survival (DFS), safety, pharmacokinetics, and immunogenicity. The primary endpoint of this study was met.

Pertuzumab has been approved in various countries and regions in combination with trastuzumab and chemotherapy for the neoadjuvant, first-line, and adjuvant treatment for certain advanced HER2-positive breast cancer.

About Henlius

Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable, and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases, and ophthalmic diseases. To date, 6 products have been launched in China, 3 have been approved for marketing in overseas markets, 24 indications are approved worldwide, and 3 marketing applications have been accepted for review in China and the EU, respectively. Since its inception in 2010, Henlius has built an integrated biopharmaceutical platform with core capabilities of high-efficiency and innovation embedded throughout the whole product life cycle including R&D, manufacturing and commercialization. It has established global innovation centre and Shanghai-based commercial manufacturing facilities certificated by China, the EU and U.S. GMP.

Henlius has proactively built a diversified and high-quality product pipeline covering over 50 molecules and has continued to explore immuno-oncology combination therapies with proprietary HANSIZHUANG (anti-PD-1 mAb) as backbone. Apart from the launched products HANLIKANG (rituximab), the first China-developed biosimilar, HANQUYOU (trastuzumab, trade name: HERCESSI™ in the U.S., Zercepac® in Europe), a China-developed mAb biosimilar approved in China, Europe and U.S., HANDAYUAN (adalimumab), HANBEITAI (bevacizumab) and HANNAIJIA (neratinib), the innovative product HANSIZHUANG has been approved by the NMPA for the treatment of MSI-H solid tumours, squamous non-small cell lung cancer (sqNSCLC) and extensive-stage small cell lung cancer (ES-SCLC), and esophageal squamous cell carcinoma (ESCC), making it the world’s first anti-PD-1 mAb for the first-line treatment of SCLC. What’s more, Henlius has conducted over 30 clinical studies for 16 products, expanding its presence in major markets as well as emerging markets.

About Organon

Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon offers more than 60 medicines and products in women’s health in addition to a growing biosimilars business and a large franchise of established medicines across a range of therapeutic areas. Organon’s existing products produce strong cash flows that support investments in innovation and future growth opportunities in women’s health and biosimilars. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets.

Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 10,000 employees with headquarters located in Jersey City, New Jersey.

For more information, visit http://www.organon.com and connect with us on LinkedIn, Instagram, X (formerly known as Twitter) and Facebook.

Cautionary Note Regarding Forward-Looking Statements

Some statements and disclosures in this press release are “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including, but not limited to, statements about expectations regarding the business plans of Organon and Henlius. Forward-looking statements may be identified by words such as “pursuing,” “opportunities,” “vision,” “will” or words of similar meaning. These statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements. Factors that could cause results to differ materially from those described in the forward-looking statements can be found in Organon’s filings with the Securities and Exchange Commission (“SEC”), including Organon’s most recent Annual Report on Form 10-K and subsequent SEC filings, available at the SEC’s Internet site (www.sec.gov).

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240930000839/en/

Permalink

https://www.aetoswire.com/en/news/3009202441824

Contacts

Organon Media:

Karissa Peer

(614) 314-8094

Hannah Silver

(917) 509-8864

Organon Investor:

Jennifer Halchak

(201) 275-2711

Henlius Media:

Bella Zhou

wenting_zhou@henlius.com

Janice Han

jiayi_han@henlius.com

 

Stonebriar Commercial Finance Announces Nicholas Sandler as Chief Executive Officer

 DALLAS - Monday, 30. September 2024 AETOSWire

(BUSINESS WIRE)--Stonebriar Commercial Finance (“Stonebriar”), a leading provider of asset-based private credit solutions with $7.3 billion of owned and serviced assets, announces that Nicholas Sandler has assumed the role of Chief Executive Officer. Sandler, who has served as Stonebriar’s President since June 2021 and co-founded the business, succeeds fellow co-founder Dave B. Fate, who is stepping down after more than 9 years of distinguished leadership. Fate will remain as Senior Advisor and Vice Chairman of Stonebriar through 2025.

Tony Minella, President of Eldridge Industries, Stonebriar’s controlling shareholder, expressed his gratitude to Fate for his extraordinary service and dedication to the company. "I met Dave over ten years ago. Our partnership has been fantastic. He has been instrumental in growing Stonebriar into the market leader it is today. Together, we’ve built significant value and have prepared the next generation of our organization to capitalize on future growth. We are deeply appreciative and proud of his contributions," said Minella.

Todd Boehly, Chairman and CEO of Eldridge Industries, voiced his trust in Sandler’s ability to lead Stonebriar into the future: "I’ve had the privilege of working closely with Nick for two decades and I couldn’t be more confident in his leadership. Nick has deep industry expertise making significant contributions to Stonebriar’s success to date and has earned the trust of our team, our clients, and our partners. I am excited to see how his determination and leadership will drive Stonebriar in the years ahead."

Fate also reflected on his time at the company: “Leading Stonebriar over the past nine years has been an incredible journey, and I’m immensely proud of what we’ve built. I am confident that Nick, as someone who has been deeply involved in the company from its inception, is the right person to guide Stonebriar into its next chapter. I look forward to seeing all that he and the team will accomplish.”

About Stonebriar Commercial Finance:
Stonebriar, an Eldridge Industries business, offers customized financing, including leases, secured term loans, and other structured finance solutions across a diverse set of industries, including manufacturing, marine, aviation, rail, energy, and real estate in North America and select foreign jurisdictions.
To learn more about Stonebriar, please visit www.StonebriarCF.com.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240930615246/en/

Permalink
https://www.aetoswire.com/en/news/3009202441831

Contacts

Media

Nadia Damouni
ndamouni@prosek.com

SLB and ADNOC Drilling Partner for Unconventional Oil and Gas Development

 

ABU DHABI, United Arab Emirates - 

Agreement will accelerate the initial scope of 144 unconventional wells for delivery by Q4 2025 with potential for significant number of additional wells in the second phase

(BUSINESS WIRE)--SLB (NYSE: SLB) today announced an agreement to create Turnwell Industries LLC OPC (Turnwell), a joint venture (JV) with ADNOC Drilling Company, SLB and Patterson-UTI. The JV will allow the three companies to leverage leading innovations in AI, smart drilling design, completions engineering and production solutions.

The JV will focus on the acceleration of UAE’s unconventional oil and gas program, with an initial 144 wells scheduled for completion by the end of 2025. SLB will provide integrated drilling, stimulation and completion services, as well as project management, digital capabilities and subsurface support as part of the venture. ADNOC Drilling through its wholly owned subsidiary ADH RSC LTD will hold a 55% majority equity stake, SLB a 30% equity stake and Patterson-UTI the remaining 15% equity stake.

"We are proud to join forces with ADNOC Drilling in this strategic partnership that demonstrates SLB’s leading position in the region deploying innovative digital, drilling and completion technologies in developing unconventional energy resources,” said Tarek Rizk, SLB’s president for the Middle East and North Africa region. ”UAE’s unconventional energy assets hold a promising future, and we are very much looking forward to elevating their performance in a safe and sustainable way.”

“Today marks a defining moment for Turnwell and our key partners SLB, and Patterson UTI. The acceleration of the well program is a testament to the innovation, collaboration and pursuit of excellence that will define our joint venture,” said Abdulrahman Abdulla Al Seiari, chief executive officer, ADNOC Drilling. “Turnwell will not only unlock the immense potential of the UAE's world-class unconventional energy resources but will also set new benchmarks for the global energy industry. We are proud to lead the way in responsibly shaping the future of energy, both in the UAE and beyond."

About SLB

SLB (NYSE: SLB) is a global technology company that drives energy innovation for a balanced planet. With a global footprint in more than 100 countries and employees representing almost twice as many nationalities, we work each day on innovating oil and gas, delivering digital at scale, decarbonizing industries, and developing and scaling new energy systems that accelerate the energy transition. Find out more at slb.com.

About ADNOC Drilling

ADNOC Drilling, listed on the Abu Dhabi Securities Exchange (ADX symbol “ADNOCDRILL”; ISIN AEA007301012), is the largest drilling and integrated drilling services (IDS) company in the Middle East by fleet size, owning and operating one of the largest multi-discipline drilling fleets in the world. The Company is a critical link in ADNOC’s upstream business, as ADNOC responsibly accelerates its production capacity targets in light of globally increasing demand for energy. ADNOC Drilling incorporated IDS into its portfolio in 2018 and now offers a total solution of start-to-finish wells and associated services. To find out more, visit: www.adnocdrilling.ae.

Cautionary Statement Regarding Forward-Looking Statements:

This press release contains “forward-looking statements” within the meaning of the U.S. federal securities laws — that is, statements about the future, not about past events. Such statements often contain words such as “expect,” “may,” “can,” “estimate,” “intend,” “anticipate,” “will,” “potential,” “projected" and other similar words. Forward-looking statements address matters that are, to varying degrees, uncertain, such as forecasts or expectations regarding the deployment of, or anticipated benefits of, SLB’s new technologies and partnerships; statements about goals, plans and projections with respect to sustainability and environmental matters; forecasts or expectations regarding energy transition and global climate change; and improvements in operating procedures and technology. These statements are subject to risks and uncertainties, including, but not limited to, the inability to achieve net-negative carbon emissions goals; the inability to recognize intended benefits of SLB’s strategies, initiatives or partnerships; legislative and regulatory initiatives addressing environmental concerns, including initiatives addressing the impact of global climate change; the timing or receipt of regulatory approvals and permits; and other risks and uncertainties detailed in SLB’s most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. If one or more of these or other risks or uncertainties materialize (or the consequences of such a development changes), or should underlying assumptions prove incorrect, actual outcomes may vary materially from those reflected in our forward-looking statements. The forward-looking statements speak only as of the date of this press release, and SLB disclaims any intention or obligation to update publicly or revise such statements, whether as a result of new information, future events or otherwise.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20240927013902/en/

Permalink

https://www.aetoswire.com/en/news/3009202441828

Contacts

Media

Josh Byerly – Vice President of Communications

Moira Duff – Director of External Communication

Tel: +1 (713) 375-3407

Email: media@slb.com

Investors

James McDonald – Senior Vice President of Investor Relations

Joy V. Domingo – Director of Investor Relations

Tel:+1 (713) 375-3535

Email: investor-relations@slb.com

Baladna Signs Agreement with Algerian National Investment Fund for Dairy and Milk Powder Production and MoU for Infant Milk Project

 

Algiers, Algeria, 30 September, 2024:

In a key development aimed at bolstering collaboration between Qatar and Algeria in agriculture and industry, Baladna Trading and Investment W.L.L., a subsidiary of Baladna Q.P.S.C., has entered into a shareholder agreement with the Algerian National Investment Fund. The agreement, signed on September 19, 2024, paves the way for establishing an integrated dairy and milk powder production project in southern Algeria, which is set to become one of the largest agricultural ventures in the region.

Additionally, Baladna signed a cooperation agreement with Algeria’s Ministry of Industry and Pharmaceutical Production to explore the feasibility of an infant milk production project. This new venture will be developed in partnership with the Algerian National Investment Fund and will complement the milk powder production project.

The signing ceremony was attended by prominent leaders including Mr. Moutaz Mohamad Raslan Al-Khayyat, Chairman of Baladna Q.P.S.C., and Algerian officials such as Minister of Finance Mr. Laaziz Fayed, Minister of Agriculture and Rural Development Mr. Youcef Chorfa, and Minister of Industry Mr. Ali Aoun. The event also saw participation from Ms. Souad Assous, Director of the Algerian National Investment Fund, and other senior officials.

The integrated dairy and milk powder production project aims to address Algeria’s growing demand for dairy products and enhance food security. Under the terms of the agreement, Baladna will hold a 51% stake, while the Algerian National Investment Fund will retain 49% ownership of the new company overseeing the project.

Mr. Kamal Mansouri, General Director of the National Investment Fund, and Mr. Ramez Mohamad Raslan Al Khayyat, Managing Director of Baladna, signed the shareholder agreement. The Memorandum of Understanding (MoU) for the infant milk project was signed by Ms. Amal Alam, General Director of Industrial Development at the Ministry of Industry, and Mr. Ramez Al Khayyat.

The infant milk project seeks to reduce Algeria’s reliance on imported powdered milk, with domestic demand ranging between 25,000 to 30,000 tons annually. The MoU outlines a comprehensive feasibility study to assess the project’s viability, focusing on technical, commercial, and financial aspects.

This collaboration is a significant milestone for Baladna as it expands into new markets while supporting Algeria's food security goals. The projects align with both nations' commitment to sustainable economic growth.

Source: AETOSWire

Contacts:
Aladdin Idilbi
A.idilbi@powerholding-intl.com